Precision BioSciences Inc. (DTIL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Precision BioSciences Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$7.47
+10.01% today
Market cap
$187M
Overall quality
38/100
Kronos AI 30-day
−0.6%
3 of 8 simulated paths end higher
Precision BioSciences Inc. (DTIL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $187M. It trades at $7.47, up 10.01% today. Its overall quality score is 38 out of 100, ranked against the whole US market. 2 analysts' average target of $45.00 implies +502.4% from today's price. Kronos AI's 30-day forecast is −0.6% (3 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $45.00 |
| Low – high | $30.00 – $60.00 |
| Analysts | 2 |
| Upside to average | +502.4% |
Kronos AI 30-day forecast
| Expected close | $6.75 (−0.6%) |
| Likely range | −4.8% … +5.3% |
| As of | 2026-10-27 |
3 of 8 simulated paths end higher.
Quality scores
| Profitability | 11 |
| Solvency | 46 |
| Growth | 57 |
| Overall | 38 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.